Aims-(1) To investigate the expression of the four main hormones of the digestive tract by performing reverse transcription polymerase chain reaction (RT-PCR) on a series ofsamples, comprising tumoral and healthy colonic tissues, hepatic metastases and colonic cell line samples; and (2) to study the patterns of labelling obtained with serological and morphological markers. Methods-After extraction and reverse transcription, gastrin, somatostatin, cholecystokinin (CCK) and transforming growth factor a (TGFa) mRNAs were detected by PCR and nested PCR using specific primers. The corresponding proteins were detected by immunohistochemistry. Results-The cell lines expressed all four mRNAs. Gastrin mRNA was present in most tumoral and metastatic samples, while the somatostatin transcript was detected in all samples and was frequently overexpressed in the normal colon. TGFa mRNA was expressed systematically in tumours of the right and transverse colon, but not in those located in the left colon; the expression of CCK mRNA was systematically absent in the left colon. Conclusions-The data presented here shed some light on the transcriptional events involved in the production of the various hormones present in the gastrointestinal tract, in both healthy and tumoral tissues. The various mRNAs expressed in cell lines are therefore not systematically expressed in the human pathology.
series ofsamples, comprising tumoral and healthy colonic tissues, hepatic metastases and colonic cell line samples; and (2) to study the patterns of labelling obtained with serological and morphological markers. Methods-After extraction and reverse transcription, gastrin, somatostatin, cholecystokinin (CCK) and transforming growth factor a (TGFa) mRNAs were detected by PCR and nested PCR using specific primers. The corresponding proteins were detected by immunohistochemistry. Results-The cell lines expressed all four mRNAs. Gastrin mRNA was present in most tumoral and metastatic samples, while the somatostatin transcript was detected in all samples and was frequently overexpressed in the normal colon. TGFa mRNA was expressed systematically in tumours of the right and transverse colon, but not in those located in the left colon; the expression of CCK mRNA was systematically absent in the left colon. Conclusions-The data presented here shed some light on the transcriptional events involved in the production of the various hormones present in the gastrointestinal tract, in both healthy and tumoral tissues. The various mRNAs expressed in cell lines are therefore not systematically expressed in the human pathology. The growth of the normal gastrointestinal mucosa, as well as that of tumours of the gastrointestinal tract, is regulated by numerous hormones and growth factors.' 2 Gastrin is an essential hormone which is present in the stomach (antrum) of adult humans; it is known to play a leading role in the secretion of gastric juice and promotes the growth of gastrointestinal epithelial cells.3 It has been established both in vivo and in vitro that it acts as a hormonal activator stimulating many gastrointestinal cancers."
Somatostatin and cholecystokinin (CCK) are also among the main hormonal mediators contributing to the trophicity of the digestive tract, probably by participating in the regulation of gastrin synthesis. 6 8-12 Transforming growth factor x (TGFa), which has an autocrine and paracrine action, also has regulatory effects on both growth and digestion in the gastrointestinal tract.'3 The results of several studies have suggested that TGFax may act as an autocrine growth factor for several colon cancer cell lines. '4 '5 Although the effects and modes of action of these hormones have been determined at the peptide level, the modes of expression of their mRNAs have not been fully elucidated in both healthy and tumoral tissues.
Most of the data available currently were derived from cell lines, where some coexpression of these hormones has been observed. In a study on colonic carcinoma cell lines-for example, gastrin and TGFca were coexpressed.'4 Gastrin and CCK were found to be coexpressed in a gastric carcinoma cell line. '6 The gastrin transcript, which has been studied particularly thoroughly, was also detected in surgical specimens"" and in paraffin wax embedded samples.20
The aim of the present study was to investigate the coexpression of gastrin, somatostatin, CCK and TGFx mRNAs in both colonic tumours and the corresponding healthy tissue. Hepatic metastases and colon cancer cell lines were also tested. The presence of the corresponding proteins was detected using immunohistochemical methods. We also examined whether there was any correlation between expression of these mRNAs, their serological concentrations and the staining pattern obtained by immunohistochemistry. 
Methods

ANALYSIS OF PCR PRODUCTS
The amplified products (10 pl) were electrophoresed through 2% agarose gels in Trisborate/EDTA buffer, stained with ethidium bromide and viewed under ultraviolet light.28
The expected PCR products are given in table 2. 
Results
GASTRIN CONCENTRATIONS
Fasting plasma gastrin concentrations were measured in eight of the 10 patients (table 3) The values were nearly normal in five patients and slightly above normal in two (cases 9 and 13).
One patient had hypergastrinaemia (case 4).
PCR
The mRNAs of all four gastrointestinal hormones were detected in the four cell lines. The gastrin transcript was readily detected in the first PCR run in the antral mucosal samples. Somatostatin mRNA was detected in antral samples, in fundic mucosa and in nine of the 10 normal colonic samples (no visible product in case 9) (data not shown). No CCK and TGFa transcripts were detected in this first amplification step.
NESTED PCR
The presence of the four mRNAs was confirmed in all four cell lines; all four mRNA transcripts were detected in the antral mucosal samples (table 4) . Gastrin mRNA was not detected in the fundic mucosa, whereas the other three transcripts were.
Gastrin mRNA was detected in nine of the 10 colonic adenocarcinomas and in five of the seven samples of hepatic metastasis; it was never detected in any of the 10 normal colonic samples.
Somatostatin mRNA was detected in normal colonic samples, colonic adenocarcinomas and in all samples of hepatic metastasis. Cases 6 and 7, however, exhibited shorter PCR products, which were detected using primers 1 and 2 with the nested PCR procedure.
Cholecystokinin mRNA was detected in four of the 10 normal colonic samples, in three of the 10 tumoral samples and in one of the seven samples of hepatic metastasis. TGFax mRNA was detected in seven of the 10 normal colonic samples, in six of the 10 tumoral samples and in six of the seven samples of hepatic metastasis.
Examples of these amplifications are given in figs 1-3.
The G3PDH control assay was always positive (data not shown). In addition, each sample was positive at least once with a given transcript, which confirms that the RNA samples tested were intact. 
Discussion
It has been established previously that gastrin acts as a growth factor and promotes the growth of human colon cancers,5 29 although the molecular mechanisms underlying its action have not been elucidated as yet. Moreover, the expression of the gastrin gene may be coupled to cellular events involved in the transformation of the colonic epithelium.'9 The determinants of this coupling are not known, but they might include the transcriptional activation of the gastrin gene by epidermal growth factor (EGF) and TGFa, which may also promote the growth of colon carcinomas. It has been suggested that TGFa may be an autocrine growth factor in colon cancers'0 and that TGFa autocrine activity contributes to the progression of tumorigenic properties of human cancer cells in the absence of changes However, to our knowledge, no studies have been carried out before on the expression of somatostatin and CCK mRNAs in metastases.
The present results confirm that TGFa (6/7) and gastrin (5/7) are both expressed at the mRNA level, and show clearly that somatostatin was expressed consistently (7/7) in all the hepatic metastatic samples. It is worth noting that two samples were found to have shorter PCR products than expected; this was probably due to splicing of the mRNA rather than to gene deletion, as the PCR carried out on the corresponding DNA always yielded the same amplification product (1225 bp24) (data not shown). It is not easy to explain these alterations. Correlations with clinical data obtained on a small number of cases have tentatively indicated that shorter PCR products are associated with a poor prognosis, but further studies are required to determine whether this is actually so. Although CCK mRNA was also detected, its expression seems to be much reduced (1/7).
Therefore, gastrin, TGFax and somatostatin are expressed in hepatic metastases, but the patterns of expression in these tumours, where the CCK mRNA levels are very low in comparison with those of the three other transcripts, differ conspicuously from those observed in the present study in the normal and tumoral colon. In previous studies, the coexpression of gastrin and TGFCx4 and that of gastrin and CCK16
has been reported in the colon and gastric cancer cell lines. In the present study, the four mRNAs (gastrin, somatostatin, CCK and TGFa) were likewise found to be coexpressed in the four colon cell lines. However, mRNAs expressed in cell lines are not expressed consistently in the human pathology. No such consistent correlations were observed in the human colon adenocarcinoma samples. Although the cell line model can provide information about the expression of the various mRNA transcripts, it cannot be perfectly representative of what takes place in human pathology. This makes the results of studies on surgical samples correlated with exact clinical data all the more valuable.
In conclusion, the data presented herein shed some light on the transcriptional events involved in the production of the various hormones present in the gastrointestinal tract, in both healthy and tumoral tissues. The regulation of mRNA expression at these sites also depends on the corresponding hormone receptors; by combining the results of studies on mRNAs encoding the main gastrointestinal hormones and their receptors with those on the expression of the corresponding proteins, it should be possible to understand in greater detail the regulatory mechanisms at work in the digestive tract and the associated pathological conditions.
A preliminary report on this study was presented at the 10th 
